Collegium Pharmaceutical (COLL) Preferred Stock Liabilities (2014 - 2015)
Collegium Pharmaceutical (COLL) posted quarterly Preferred Stock Liabilities of $11.3 million for Q1 2015, down 11.24% quarter-over-quarter from $12.8 million in Q4 2014.
Collegium Pharmaceutical (COLL) Preferred Stock Liabilities (2014 - 2015) Analysis & Trends
Collegium Pharmaceutical's Preferred Stock Liabilities history runs 2 years deep, the most recent figure standing at $11.3 million for Q1 2015.
- In Q1 2015, Preferred Stock Liabilities changed N/A year-over-year to $11.3 million; the TTM figure through Mar 2015 stood at $11.3 million (changed N/A YoY), while the FY2014 annual figure was $12.8 million, down 74.11% from the prior year.
- Preferred Stock Liabilities for Q1 2015 stood at $11.3 million, down from $12.8 million in the prior quarter.
- The five-year high for Preferred Stock Liabilities was $12.8 million in Q4 2014, with the low at $11.3 million in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Collegium Pharmaceutical | 887.48 Mn | 738.16 Mn | 110.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | 11.35 Mn |
| Dec 31, 2014 | 12.78 Mn |